Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Kühnl, A
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jul 2017 - 1540-1546 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
1569-8041
10.1093/annonc/mdx128 doi
Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Biomarkers, Tumor--genetics
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
Gene Rearrangement
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Middle Aged
Multivariate Analysis
Patient Selection
Precision Medicine
Prednisone--administration & dosage
Proto-Oncogene Proteins c-bcl-2--genetics
Proto-Oncogene Proteins c-bcl-6--genetics
Proto-Oncogene Proteins c-myc--genetics
Risk Factors
Rituximab
Time Factors
Treatment Outcome
United Kingdom
Vincristine--administration & dosage
Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jul 2017 - 1540-1546 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
1569-8041
10.1093/annonc/mdx128 doi
Age Factors
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Biomarkers, Tumor--genetics
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
Gene Rearrangement
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse--drug therapy
Male
Middle Aged
Multivariate Analysis
Patient Selection
Precision Medicine
Prednisone--administration & dosage
Proto-Oncogene Proteins c-bcl-2--genetics
Proto-Oncogene Proteins c-bcl-6--genetics
Proto-Oncogene Proteins c-myc--genetics
Risk Factors
Rituximab
Time Factors
Treatment Outcome
United Kingdom
Vincristine--administration & dosage